ARCHIVES

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

This article is from The Cancer Letter archive.

Vol. 26 No. 28 | July 14, 2000

Download PDF Visit The Full Archive

Related Articles

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter.

November 16, 2007

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000